IWC
CARM

Integrated Wealth Concepts’s Carisma Therapeutics CARM Stock Holding History

Integrated Wealth Concepts’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$12K – 1352
2022
Q4 		$12K Hold
1,000
– – ﹤0.01% 1031
2022
Q3 		$9K Hold
1,000
– – ﹤0.01% 948
2022
Q2 		$16K Hold
1,000
– – ﹤0.01% 973
2022
Q1 		$12K Buy
+1,000
New +$14K ﹤0.01% 934
2021
Q4 		– Sell
-1,250
Closed -$20K – 988
2021
Q3 		$20K Buy
1,250
+617
+97% +$29.6K ﹤0.01% 934
2021
Q2 		$59K Buy
633
+92
+17% +$5.87K ﹤0.01% 794
2021
Q1 		$28K Buy
+541
New +$25.5K ﹤0.01% 729

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Integrated Wealth Concepts's CARM Position: Q1 2023 in Review

Integrated Wealth Concepts sold out of Carisma Therapeutics (CARM) in Q1 2023, closing a stake of 1,000 shares — an estimated $12K sold.

Integrated Wealth Concepts first reported a position in CARM in Q1 2021 and held it in 7 quarters. The position peaked at $59K in Q2 2021. 37 funds tracked by Wall St. Rank hold CARM as of Q1 2023.

  • Integrated Wealth Concepts reported no remaining Carisma Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Integrated Wealth Concepts sold 1,000 Carisma Therapeutics shares in Q1 2023, an estimated $12K.
  • Integrated Wealth Concepts first reported a position in Carisma Therapeutics in Q1 2021 and held it in 7 quarters.
  • Integrated Wealth Concepts's Carisma Therapeutics position peaked at $59K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2023.

Based on Integrated Wealth Concepts's 13F filing for Q1 2023, filed 3 May 2023.